Bristol-Myers Squibb gets FDA breakthrough designation for daclatasvir-based regimen - 0 views
-
PBR Staff Writer Published 25 February 2014 Bristol-Myers Squibb (BMS) has received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA) for its investigational DCV Dual Regimen (daclatasvir and asunaprevir) for use as a combination therapy in the treatment of genotype 1b chronic hepatitis C infection (HCV).
The Diabetes Breakthrough Your Doctor Won't Tell You About - 0 views
-
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Please Note: The material on this site is provided for informational purposes only and is not medical advice. Always consult your physician before beginning any diet or exercise program.
Doctors praise 'world's first full face transplant' - Telegraph - 0 views
Why Acne develops in teenagers - 0 views
Why acne develops in teenage girls. | Manage the acne breakthrough. - 0 views
Supplement clinically proven to reduce CELLULAR AGING to that of a 20 year old... - 0 views
Are you concerned about? CANCER, DIABETES, HEART DISEASE, DEPRESSION, HIGH BLOOD PRESSURE? Watch this video: http://www.abcliveit.com Listen here: 712-432-9242 Clinically proven to reduce CELLUL...
Your tongue tells you about your health. | Manage the acne breakthrough. - 0 views
1 - 13 of 13
Showing 20▼ items per page